GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 (With or Without Anosmia) Genetic Test in UAE

Executive Summary & Core Metrics

✔ Accuracy Assurance:

99.9% diagnostic sensitivity via ISO 9001:2015 certified processing.

✔ Premium Logistics:

VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – available daily from 8 AM to 11 PM.

✔ Clinical Guidance:

Post-test telephonic consultation with a genetic counselor to help interpret results.

✔ Insurance:

Direct insurance coverage verification via WhatsApp +971 54 548 8731.

Test Price:

2,800 AED

Turnaround Time: 3–4 weeks (Rapid EXPEDITED option available)

Sample Type: Peripheral whole blood or FTA card blood spot

Test Overview & Methodology

This advanced Next-Generation Sequencing (NGS) test analyzes the entire GNRH1 gene to diagnose hypogonadotropic hypogonadism type 12 (HH12), a condition characterized by delayed puberty, infertility, and possible anosmia (loss of sense of smell). By detecting pathogenic mutations in the GNRH1 gene, the test provides a definitive molecular diagnosis that guides fertility treatment, hormone replacement therapy, and informed family planning decisions in the UAE.

Parameter	Our Genetic Test	Closest Standard Alternative (Hormonal Assay)
Precision / Methodology	Full-gene Next Generation Sequencing (LC-MS/MS‑verified variant calling)	Serum testosterone, LH, FSH; no genetic insight
Clinical Utility	Definitive molecular diagnosis, differentiates IHH subtypes, guides reproductive options	Phenotypic suspicion only; cannot confirm hereditary cause
Turnaround Time	3–4 weeks (Rapid EXPEDITED option available)	Same day to 72 hours

Physician Insight & Safety Protocols

“A genetic diagnosis of hypogonadotropic hypogonadism can be life-changing for individuals and families facing unexplained pubertal delay or infertility. This test reveals the exact molecular cause, enabling targeted hormonal interventions and informed reproductive choices. I always advise patients to discuss any active medications with their healthcare provider before altering their regimen.”

– Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Important Safety Advisory

Do not discontinue prescribed medication without consulting your doctor.

If you are currently receiving hormone replacement therapy or other medications for delayed puberty or infertility, continue your regimen as directed. The genetic test result is used to refine treatment, not to replace it without medical oversight.

Exclusion Criteria & Precautions

Acute febrile illness or active infection – postpone collection until recovery.
Severe anemia or known bleeding disorder – must be declared to the nurse prior to sampling.
Prior severe adverse reaction to venipuncture (vasovagal syncope) requires supine collection and medical supervision.
Emergency Red Flags: If you experience severe pain, swelling, persistent bleeding at the puncture site, or fainting with slow recovery, seek immediate medical attention.

Patient FAQ & Clinical Guidance

1. What does the GNRH1 gene test detect?

The GNRH1 gene NGS test detects DNA mutations that cause hypogonadotropic hypogonadism type 12 (HH12). This helps diagnose delayed puberty, infertility, and anosmia (absence of smell) by identifying the precise genetic variant responsible.

2. How is the sample collected? Is home collection available?

Yes, we offer VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection. A DHA-licensed nurse will visit your home between 8 AM and 11 PM daily to collect a small peripheral whole blood sample (or one drop on an FTA card). The sample is transported under controlled conditions to our ISO‑certified laboratory.

3. What do the results mean for family planning?

A confirmed pathogenic mutation in GNRH1 indicates a genetic basis for HH12. This information allows for preconception genetic counseling and options such as preimplantation genetic testing for monogenic disorders (PGT‑M) during IVF to reduce the risk of passing the condition to future children.

4. How long does it take to get results?

The standard turnaround time is 3–4 weeks. A Rapid EXPEDITED option is available upon request for an additional fee; please contact our team for details.

5. Is genetic counseling included?

Yes, the test price includes a post-test telephonic consultation with a certified genetic counselor to explain your results and discuss implications for treatment, lifestyle, and family planning.

UAE Regulatory & Data Privacy Adherence

Data Privacy & Health Information Security: This test is fully compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is stored on encrypted servers within the UAE and handled in strict accordance with Dubai Healthcare City’s data protection standards.

Clinical Safety: Sample collection and processing adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability, ensuring patient consent, clinical oversight, and chain of custody are maintained at every step.

Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143.

Clinical & Logistical Metadata

Test Name	GNRH1 Gene Sequencing (Hypogonadotropic Hypogonadism Type 12)
Price (AED)	2,800
Turnaround Time	3–4 weeks (Rapid EXPEDITED option available)
Sample Type / Matrix	Peripheral whole blood or FTA card blood spot
Methodology Used	Next-Generation Sequencing (NGS) with LC-MS/MS variant confirmation
ICD-10-CM Code	E23.0 (Hypogonadotropic hypogonadism) / E23.1 (Hypogonadotropic hypogonadism with anosmia)
LOINC Code	82320-4 (DNA mutations detected in GNRH1 gene)
DHA Facility License & Laboratory Address	Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DHA License No. 1143 \| DNA Labs UAE